Cargando…
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
SUMMARY: Osteoporosis causes an elevated fracture risk. We propose the continued use of T-scores as one means for diagnosis but recommend that, alternatively, hip fracture; osteopenia-associated vertebral, proximal humerus, pelvis, or some wrist fractures; or FRAX scores with ≥3 % (hip) or 20 % (maj...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988515/ https://www.ncbi.nlm.nih.gov/pubmed/24577348 http://dx.doi.org/10.1007/s00198-014-2655-z |
_version_ | 1782312029345808384 |
---|---|
author | Siris, E. S. Adler, R. Bilezikian, J. Bolognese, M. Dawson-Hughes, B. Favus, M. J. Harris, S. T. Jan de Beur, S. M. Khosla, S. Lane, N. E. Lindsay, R. Nana, A. D. Orwoll, E. S. Saag, K. Silverman, S. Watts, N. B. |
author_facet | Siris, E. S. Adler, R. Bilezikian, J. Bolognese, M. Dawson-Hughes, B. Favus, M. J. Harris, S. T. Jan de Beur, S. M. Khosla, S. Lane, N. E. Lindsay, R. Nana, A. D. Orwoll, E. S. Saag, K. Silverman, S. Watts, N. B. |
author_sort | Siris, E. S. |
collection | PubMed |
description | SUMMARY: Osteoporosis causes an elevated fracture risk. We propose the continued use of T-scores as one means for diagnosis but recommend that, alternatively, hip fracture; osteopenia-associated vertebral, proximal humerus, pelvis, or some wrist fractures; or FRAX scores with ≥3 % (hip) or 20 % (major) 10-year fracture risk also confer an osteoporosis diagnosis. INTRODUCTION: Osteoporosis is a common disorder of reduced bone strength that predisposes to an increased risk for fractures in older individuals. In the USA, the standard criterion for the diagnosis of osteoporosis in postmenopausal women and older men is a T-score of ≤ −2.5 at the lumbar spine, femur neck, or total hip by bone mineral density testing. METHODS: Under the direction of the National Bone Health Alliance, 17 clinicians and clinical scientists were appointed to a working group charged to determine the appropriate expansion of the criteria by which osteoporosis can be diagnosed. RESULTS: The group recommends that postmenopausal women and men aged 50 years should be diagnosed with osteoporosis if they have a demonstrable elevated risk for future fractures. This includes having a T-score of less than or equal to −2.5 at the spine or hip as one method for diagnosis but also permits a diagnosis for individuals in this population who have experienced a hip fracture with or without bone mineral density (BMD) testing and for those who have osteopenia by BMD who sustain a vertebral, proximal humeral, pelvic, or, in some cases, distal forearm fracture. Finally, the term osteoporosis should be used to diagnose individuals with an elevated fracture risk based on the World Health Organization Fracture Risk Algorithm, FRAX. CONCLUSIONS: As new ICD-10 codes become available, it is our hope that this new understanding of what osteoporosis represents will allow for an appropriate diagnosis when older individuals are recognized as being at an elevated risk for fracture. |
format | Online Article Text |
id | pubmed-3988515 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-39885152014-04-23 The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group Siris, E. S. Adler, R. Bilezikian, J. Bolognese, M. Dawson-Hughes, B. Favus, M. J. Harris, S. T. Jan de Beur, S. M. Khosla, S. Lane, N. E. Lindsay, R. Nana, A. D. Orwoll, E. S. Saag, K. Silverman, S. Watts, N. B. Osteoporos Int Position Paper SUMMARY: Osteoporosis causes an elevated fracture risk. We propose the continued use of T-scores as one means for diagnosis but recommend that, alternatively, hip fracture; osteopenia-associated vertebral, proximal humerus, pelvis, or some wrist fractures; or FRAX scores with ≥3 % (hip) or 20 % (major) 10-year fracture risk also confer an osteoporosis diagnosis. INTRODUCTION: Osteoporosis is a common disorder of reduced bone strength that predisposes to an increased risk for fractures in older individuals. In the USA, the standard criterion for the diagnosis of osteoporosis in postmenopausal women and older men is a T-score of ≤ −2.5 at the lumbar spine, femur neck, or total hip by bone mineral density testing. METHODS: Under the direction of the National Bone Health Alliance, 17 clinicians and clinical scientists were appointed to a working group charged to determine the appropriate expansion of the criteria by which osteoporosis can be diagnosed. RESULTS: The group recommends that postmenopausal women and men aged 50 years should be diagnosed with osteoporosis if they have a demonstrable elevated risk for future fractures. This includes having a T-score of less than or equal to −2.5 at the spine or hip as one method for diagnosis but also permits a diagnosis for individuals in this population who have experienced a hip fracture with or without bone mineral density (BMD) testing and for those who have osteopenia by BMD who sustain a vertebral, proximal humeral, pelvic, or, in some cases, distal forearm fracture. Finally, the term osteoporosis should be used to diagnose individuals with an elevated fracture risk based on the World Health Organization Fracture Risk Algorithm, FRAX. CONCLUSIONS: As new ICD-10 codes become available, it is our hope that this new understanding of what osteoporosis represents will allow for an appropriate diagnosis when older individuals are recognized as being at an elevated risk for fracture. Springer London 2014-02-28 2014 /pmc/articles/PMC3988515/ /pubmed/24577348 http://dx.doi.org/10.1007/s00198-014-2655-z Text en © The Author(s) 2014 https://creativecommons.org/licenses/by-nc/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Position Paper Siris, E. S. Adler, R. Bilezikian, J. Bolognese, M. Dawson-Hughes, B. Favus, M. J. Harris, S. T. Jan de Beur, S. M. Khosla, S. Lane, N. E. Lindsay, R. Nana, A. D. Orwoll, E. S. Saag, K. Silverman, S. Watts, N. B. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group |
title | The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group |
title_full | The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group |
title_fullStr | The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group |
title_full_unstemmed | The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group |
title_short | The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group |
title_sort | clinical diagnosis of osteoporosis: a position statement from the national bone health alliance working group |
topic | Position Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988515/ https://www.ncbi.nlm.nih.gov/pubmed/24577348 http://dx.doi.org/10.1007/s00198-014-2655-z |
work_keys_str_mv | AT sirises theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT adlerr theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT bilezikianj theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT bolognesem theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT dawsonhughesb theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT favusmj theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT harrisst theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT jandebeursm theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT khoslas theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT lanene theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT lindsayr theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT nanaad theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT orwolles theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT saagk theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT silvermans theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT wattsnb theclinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT sirises clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT adlerr clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT bilezikianj clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT bolognesem clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT dawsonhughesb clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT favusmj clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT harrisst clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT jandebeursm clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT khoslas clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT lanene clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT lindsayr clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT nanaad clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT orwolles clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT saagk clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT silvermans clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup AT wattsnb clinicaldiagnosisofosteoporosisapositionstatementfromthenationalbonehealthallianceworkinggroup |